Circulation-heart Failure

Journal Title：Circulation-heart Failure

Circulation: Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance. As a primarily clinical journal, few basic and preclinical studies are ultimately published. Those that will be considered are novel, and significantly and directly advance the field of heart failure. The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models. Less than 15% of submitted articles are ultimately published. Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.

《循环：心力衰竭》杂志考虑发表与心力衰竭、机械循环支持和心脏移植科学和医学相关的内容，包括对人类进行的研究或对人类数据的分析，以及具有直接临床相关性或相关性的临床前研究。作为一本主要针对临床的杂志，最终发表的基础研究和临床前研究很少。那些将被考虑的研究都是新颖的，并且对心力衰竭领域有重大而直接的推动作用。编辑们对与心力衰竭直接相关的基础科学研究特别感兴趣，这些研究信息量大，可转化为人类疾病，并在脊椎动物模型中进行。提交的文章中，只有不到 15% 最终得以发表。不直接涉及心力衰竭或心力衰竭治疗的研究将不予考虑，包括在没有心力衰竭底物的情况下研究心肌梗死、再灌注损伤或心律失常的机制。

Circulation-heart Failure创刊于2008年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵盖医学 - 心血管系统全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度 较慢,6-12周 ，影响因子指数7.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。